Skip to main content
. 2020 Dec 3;11:594549. doi: 10.3389/fphar.2020.594549

TABLE 1.

Summary of key features of HTA agencies.

Jurisdiction Regulatory approval HTA assessment and appraisal Main HTA criteria Influence of HTA on drug pricing Managed entry scheme
Australia National National Clinical, cost effectiveness Indirectly as it has an impact on ICER Yes
Canada National National and regional Clinical, cost effectiveness Indirectly as it has an impact on ICER Yes
England Pan- European National Clinical, cost effectiveness Indirectly as it has an impact on ICER Yes
France National Clinical Yes, ASMR rating used for pricing negotiation Yes
Germany National Clinical Indirectly through the level of added benefit No
Italy National and regional Clinical, budget impact Yes Yes
Spain National and regional Clinical, budget impact Yes Yes